Aβ43 is the earliest depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
Aβ43 is the earliest depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
复制标题
Aβ43是APP转基因小鼠大脑中最早沉积的Aβ种类,并通过ACE的两个活性结构域转化为Aβ41。
DOI:
10.1016/j.ajpath.2013.01.053
复制
发表时间:
2013
期刊:
影响因子:
6
通讯作者:
Komano H
中科院分区:
文献类型:
--
作者:
Zou K;Liu J;Watanabe A;Hiraga S;Liu S;Tanabe C;Maeda T;Terayama Y;Takahashi S;Michikawa M;Komano H
Amyloid-β protein (Aβ) varies in length at its carboxyl terminus. The longer Aβ species, Aβ43and Aβ42, are highly amyloidogenic and deposit more frequently than Aβ40in the brain of Alzheimer disease (AD) patients. However, the characterization of Aβ43deposition in the brain and the relationship between Aβ43and Aβ42or Aβ40remain unclear. We provide evidence that Aβ43deposition appears earlier than Aβ42and Aβ40deposition in the brain of mutant amyloid precursor protein transgenic (APPtg) mice, suggesting that Aβ43is the earliest-depositing species. In addition, we found increased Aβ43levels and Aβ43/Aβ42ratios in the serum of AD patients, suggesting their use as diagnostic blood biomarkers for AD. We further show that angiotensin-converting enzyme (ACE) converts Aβ43to Aβ41. Notably, this Aβ43-to-Aβ41converting activity requires two active domains of ACE. Inhibition of ACE activity significantly enhanced Aβ43deposition in APPtg mouse brain. Our results suggest that Aβ43is the earliest-depositing species in brain parenchyma and that Aβ43may trigger later Aβ42and Aβ40deposition or may be converted to Aβ42and Aβ40plaques. Activities of both ACE domains may be important for reducing Aβ43levels in serum and reducing brain Aβ43deposition.